Therapeutic Plasmapheresis Enabling Radioactive Iodine Treatment in a Patient with Thyrotoxicosis

J Korean Med Sci. 2015 Oct;30(10):1531-4. doi: 10.3346/jkms.2015.30.10.1531. Epub 2015 Sep 12.

Abstract

Therapeutic plasma exchange (TPE) is one possible treatment for patients resistant to conventional antithyroid drugs or requiring urgent attention for thyrotoxicosis. We report a 35-yr-old man with thyrotoxicosis, ultimately attributed to Graves' disease in whom antithyroid drug used initially was soon discontinued, due to abnormal liver function, and replaced by Lugol's solution. Three weeks later, an escape phenomenon (to Lugol's solution) was apparent, so we performed TPE to control the thyrotoxicosis. Two courses of TPE by a centrifugal type machine resulted in diminished levels of thyroid hormone levels, which then rebounded after another two courses of membrane filtration type TPE. However, the patient could be treated with radioactive iodine therapy without any complications at present.

Keywords: Graves Disease; Plasmapheresis; Thyrotoxicosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antithyroid Agents / adverse effects
  • Antithyroid Agents / therapeutic use
  • Cetirizine / adverse effects
  • Cetirizine / therapeutic use
  • Graves Disease / radiotherapy*
  • Hepatitis B, Chronic / complications
  • Humans
  • Iodides / therapeutic use
  • Iodine Radioisotopes / therapeutic use*
  • Male
  • Methimazole / adverse effects
  • Methimazole / therapeutic use
  • Plasmapheresis / methods*
  • Thyroid Gland / pathology*
  • Thyrotoxicosis / therapy*

Substances

  • Antithyroid Agents
  • Iodides
  • Iodine Radioisotopes
  • Methimazole
  • levocetirizine
  • Lugol's solution
  • Cetirizine